Delivery Pathway Regulation of 3',3"-Bis-Peptide-siRNA Conjugate via Nanocarrier Architecture Engineering
Small interfering RNA (siRNA) has been continuously explored for clinical applications. However, neither nanocarriers nor conjugates have been able to remove the obstacles. In this study, we employed a combined nanochemistry strategy to optimize its delivery dilemma, where different interactions and...
Saved in:
Main Authors: | Jing Sun (Author), Chong Qiu (Author), Yiping Diao (Author), Wei Wei (Author), Hongwei Jin (Author), Yi Zheng (Author), Jiancheng Wang (Author), Lihe Zhang (Author), Zhenjun Yang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibody-siRNA conjugates (ARC): Emerging siRNA drug formulation
by: Weiran Cao, et al.
Published: (2022) -
Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
by: Alexey Berezhnoy, et al.
Published: (2012) -
LDLR-Mediated Targeting and Productive Uptake of siRNA-Peptide Ligand Conjugates In Vitro and In Vivo
by: Baptiste Broc, et al.
Published: (2024) -
Oleyl Conjugated Histidine-Arginine Cell-Penetrating Peptides as Promising Agents for siRNA Delivery
by: Muhammad Imran Sajid, et al.
Published: (2022) -
Gelofusine Attenuates Tubulointerstitial Injury Induced by cRGD-Conjugated siRNA by Regulating the TLR3 Signaling Pathway
by: Bohong Cen, et al.
Published: (2018)